Structures by: Riche C.
Total: 45
PNOX
C24H19NO5
Org. Biomol. Chem. (2003) 1, 15 2689-2698
a=9.726(3)Å b=18.482(5)Å c=11.049(3)Å
α=90.00° β=102.86(3)° γ=90.00°
3,11-dibenzoyl-6,13dimethyl-7,14-dioxo-2,10-diphenyl-1,9-dioxa- 2,6,10,13-tetraazaspiro[4.2.2.4]tetradecane
C36H32N4O6
Journal of the Chemical Society, Perkin Transactions 1 (2000) 7 1095
a=8.932(2)Å b=9.670(3)Å c=10.105(2)Å
α=100.95(2)° β=105.61(2)° γ=106.37(2)°
[N-(1'-Phenylethyl)-2-azabicyclo[4,3,0]-6-allyl-8,8-dimethyl-3-oxonon -5-yl]-carboxylic acid
C22H27NO3
Acta Crystallographica Section C (1998) 54, 3 401-403
a=13.154(7)Å b=13.154(7)Å c=11.869(8)Å
α=90.00° β=90.00° γ=90.00°
Baccatin III derivative
C26H44O8Si
Acta Crystallographica Section C (1995) 51, 3 465-468
a=8.323(4)Å b=10.569(5)Å c=17.022(10)Å
α=90.00° β=100.15(2)° γ=90.00°
Ethyl 3-(4-chlorophényl)-3a-méthyl- 5-phényl-3,3a,4,11-tétrahydro-3H-[1,2,4] triazolo [4,3-a] [1,5] benzodiazépine
C26H23ClN4O2
Acta Crystallographica Section C (1995) 51, 5 961-963
a=10.207(8)Å b=26.978(12)Å c=8.744(6)Å
α=90.00° β=106.96(3)° γ=90.00°
2α,3α,7β,13β-diépoxy-trans-himachalane.
C15H24O2
Acta Crystallographica Section C (1995) 51, 6 1171-1173
a=8.017(2)Å b=11.103(3)Å c=8.263(3)Å
α=90.00° β=111.53(4)° γ=90.00°
C20H20N2O3
C20H20N2O3
Acta Crystallographica, Section C: Crystal Structure Communications (1995) 51, 1 91-93
a=5.607(2)Å b=10.954(3)Å c=27.452(15)Å
α=90.00° β=90.00° γ=90.00°
Méthyl (2R,5S)-1-N-benzyl-5-méthoxycarbonylprolyl-(2S)-phénylalaninate
C24H28N2O5
Acta Crystallographica Section C (1997) 53, 4 459-461
a=7.473(2)Å b=13.971(6)Å c=21.769(11)Å
α=90.00° β=90.00° γ=90.00°
(3R),(2S)-2'-N-Dibenzylamino-1,2:5,6-diisopropylidène-α-D-allofuranos-3- spiro-β-propiolactone
C28H33NO7
Acta Crystallographica Section C (1997) 53, 4 457-459
a=32.156(13)Å b=7.114(2)Å c=12.118(6)Å
α=90.00° β=101.47(6)° γ=90.00°
3α, 4α, 8α, 9α-diépoxy-cis-himachalane
C15H24O2
Acta Crystallographica Section C (1996) 52, 12 3240-3243
a=8.542(6)Å b=13.823(8)Å c=22.941(12)Å
α=90.00° β=90.00° γ=90.00°
11-12 dihydro, 7-triethylsilyl, 10-deacetylbaccatin III.
C35H52O10Si
Acta Crystallographica Section C (1995) 51, 10 2050-2053
a=8.517(6)Å b=15.512(9)Å c=25.925(14)Å
α=90.00° β=90.00° γ=90.00°
(1S,2R,3R,4S)-1,2-oxydo-3-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline
C16H15NO
Acta Crystallographica Section C (1995) 51, 10 2047-2050
a=9.130(7)Å b=15.082(12)Å c=9.506(7)Å
α=90.00° β=100.36(3)° γ=90.00°
(1S,2R,3R,4S)-N-methyl-1,2-oxydo-3-methyl-4-phenyl-1,2,3,4- tetrahydroisoquinolinium
C17H18NO,BF4
Acta Crystallographica Section C (1995) 51, 10 2047-2050
a=8.448(2)Å b=9.383(3)Å c=21.140(7)Å
α=90.00° β=90.00° γ=90.00°
2α,3α,7β,8β-diépoxy-trans-himachalane
C15H24O2
Acta Crystallographica Section C (1996) 52, 10 2502-2504
a=7.948(5)Å b=10.902(2)Å c=8.220(5)Å
α=90.00° β=106.43(3)° γ=90.00°
2α ,3α ,6α ,7α-diépoxyhimachalane
C15H24O2
Acta Crystallographica Section C (1996) 52, 10 2504-2507
a=8.537(2)Å b=8.221(2)Å c=10.364(2)Å
α=90.00° β=104.31(2)° γ=90.00°
L-2-(1,2:5,6-di-O-isopropylidène-α-D-allofuranos-3-yl) dibenzyl-tert- butyle glycinate
C32H43NO8
Acta Crystallographica Section C (1994) 50, 1 110-112
a=13.679(4)Å b=15.182(4)Å c=15.390(3)Å
α=90.00° β=90.00° γ=90.00°
1-mésityl-3a-méthyl-5-phényl-3,3a,4,11-tétrahydro-3H-[1,2,4] oxadiazolo [4,5-a] [1,5] benzodiazépine
C26H25N3O
Acta Crystallographica Section C (1995) 51, 9 1898-1900
a=8.521(3)Å b=15.367(6)Å c=16.892(6)Å
α=90.00° β=90.00° γ=90.00°
(2R,3S,4S) 1-[(1S)-1-phenylethyl]-3-hydroxy-2-hydroxymethyl-4-methyl pyrrolidine
C14H21NO2
Acta Crystallographica Section C (1995) 51, 9 1859-1861
a=6.593(4)Å b=10.237(5)Å c=20.219(10)Å
α=90.00° β=90.00° γ=90.00°
C13H16N2O5
C13H16N2O5
Acta Crystallographica Section C (1992) 48, 12 2194-2196
a=10.307(3)Å b=9.364(3)Å c=7.394(2)Å
α=90° β=104.65(2)° γ=90°
2α, 3α,-7α, 13α-diépoxyhimachalane
C15H24O2
Acta Crystallographica Section C (1992) 48, 9 1720-1722
a=6.548(2)Å b=9.685(2)Å c=21.282(8)Å
α=90.00° β=90.00° γ=90.00°
Cerleaside-A
C30H44O8,H2O
Acta Crystallographica Section C (1993) 49, 11 2020-2022
a=7.687(3)Å b=11.553(5)Å c=16.003(8)Å
α=90.00° β=91.26(3)° γ=90.00°
2H,3H-2-phenyl-3,4-dimethyl-6-carbonitrile 2R-[2α,3α,6β,9α]- hexahydropyrido [2,1-b][1,3,4] oxadiazin
C16H21N3O1
Acta Crystallographica Section C (1993) 49, 10 1786-1789
a=8.934(3)Å b=11.556(4)Å c=14.884(6)Å
α=90.00° β=90.00° γ=90.00°
2H,3H-2-phenyl-3,4-dimethyl-6-carbonitrile 2S-[2β,3α,6β,9β]- hexahydropyrido [2,1-b][1,3,4] oxadiazin
C16H21N3O1
Acta Crystallographica Section C (1993) 49, 10 1786-1789
a=11.756(4)Å b=7.564(3)Å c=17.261(8)Å
α=90.00° β=99.78(5)° γ=90.00°
(+-)-p-nitrobenzyl 2-(2,2-dimethyl-1-phenylpropylamino)-1-cyclopentene-1-carboxylate
C24H28N2O4
Acta Crystallographica Section C (1993) 49, 7 1406-1409
a=6.3630(10)Å b=13.536(2)Å c=25.703(4)Å
α=90.00° β=91.74(3)° γ=90.00°
(2S,3R)-2-amino-3-hydroxyl-3-(1,2:3,4-di-o-isopropylidène- α-D-galactopyranos-5-yl) propanoate de méthyle
C15H25NO8
Acta Crystallographica Section C (1993) 49, 4 828-830
a=5.648(2)Å b=26.369(8)Å c=11.868(4)Å
α=90.00° β=90.19(2)° γ=90.00°
Bis(π-allylhimachalène) α,α-dichlorodipalladium
C30H46Cl2Pd2
Acta Crystallographica Section C (1993) 49, 2 365-368
a=10.059(7)Å b=10.226(7)Å c=29.416(15)Å
α=90.00° β=90.00° γ=90.00°
(+-)-3-methyl-1-diphenyl-2-butyl 3-acetamidocrotonate
C23H27NO3
Acta Crystallographica Section C (1995) 51, 5 967-970
a=11.049(4)Å b=18.659(6)Å c=11.602(4)Å
α=90.00° β=117.08(2)° γ=90.00°
(+-)-3-methyl-1-diphenyl-2-butyl 3-acetamidobutanoate
C23H29NO3
Acta Crystallographica Section C (1995) 51, 5 967-970
a=22.41(3)Å b=20.76(2)Å c=9.195(6)Å
α=90.00° β=90.00° γ=90.00°
4-benzyl-6-methoxy-3-propylsulfonyl-2-(2,2,2',2'-tetramethyl-[4,4'] bi{[1,3]dioxolanyl}-5-yl)-1-aza-bicyclo[3.2.0]heptane-7-one
C27H39NO8S
Acta Crystallographica Section C (1995) 51, 7 1306-1310
a=7.244(5)Å b=14.863(8)Å c=27.308(12)Å
α=90.00° β=90.00° γ=90.00°
3-ethylsulfuryl-4-furan-2-yl-methyl-6-methoxy-2- (2,2,2',2'-tetramethyl-[4,4']bi[[1,3] dioxolanyl]-5-yl) -1-aza-bicyclo[3.2.0] heptane-7-one
C24H35NO7S
Acta Crystallographica Section C (1995) 51, 7 1306-1310
a=10.136(6)Å b=10.136(6)Å c=25.026(12)Å
α=90.00° β=90.00° γ=90.00°
1,7-diéthoxycarbonyl-3a-méthyl-4a-phényl- 3,5-diparanitrophényl-3a,4,4a,5-tétrahydro-3H-bis[1,2,4] triazolo[4,3-a:3,4'-d][1,5]benzodiazépine
C36H32N8O8,C1H1Cl3
Acta Crystallographica Section C (1995) 51, 7 1352-1355
a=12.044(7)Å b=12.461(7)Å c=13.730(8)Å
α=104.33(3)° β=94.47(3)° γ=101.00(3)°
(1R,2R,5(1)S,9R,2'R,4'R,5'S)-2,10,10- triméthyl-3-oxa-6-azatricyclo[7.1.1.0^2,7^]undeca-5-spiro[1'(2',4',5'- triméthylcyclohexane)]-6-ène-4-one
C20H31NO2
Acta Crystallographica Section C (1994) 50, 7 1122-1124
a=6.241(6)Å b=7.319(7)Å c=10.505(15)Å
α=84.65(3)° β=94.83(2)° γ=100.80(3)°
1-Tosyl-1H-pyrrolo[2,3-c]pyridine-5-carboxylic Acid Ethyl Ester
C17H16N2O4S
Acta Crystallographica Section C (1994) 50, 8 1343-1345
a=5.088(3)Å b=11.566(8)Å c=14.909(12)Å
α=110.32(3)° β=96.62(3)° γ=91.42(3)°
4,7,7,12-Tetramethyl-2-oxa-tricyclo[6.4.0.0 ^4,9^]dodecane-3(R),12(R)-diol
C15H26O3
Acta Crystallographica Section C (1998) 54, 12 1964-1965
a=7.449(3)Å b=10.724(4)Å c=17.733(10)Å
α=90.00° β=90.00° γ=90.00°
C20H20N2O3
C20H20N2O3
Acta Crystallographica Section C (1995) 51, 91-93
a=5.607(2)Å b=10.954(3)Å c=27.452(15)Å
α=90.00° β=90.00° γ=90.00°
Haperforine B1
C27H32O9
Acta Crystallographica Section C (2000) 56, 6 711-713
a=12.216(4)Å b=12.463(5)Å c=16.781(7)Å
α=90.00° β=90.00° γ=90.00°
Haperforin D
C27H34O10
Acta Crystallographica Section C (2000) 56, 6 711-713
a=10.148(5)Å b=11.225(7)Å c=11.356(8)Å
α=90.00° β=99.44(2)° γ=90.00°
(1S,4R,5R,6R)-(6-(methoxycarbonyl)-2-(pivaloyloxymethyl)-4- (pivaloyloxy)bicyclo[3.1.0]hex-2-en-1-yl)-1-carboxylic acid
C20H28O8
Acta Crystallographica Section C (2000) 56, 3 358-359
a=8.869(2)Å b=9.836(2)Å c=12.225(6)Å
α=90.00° β=91.40(3)° γ=90.00°
7-benzoyl-2-(4-methoxyphenyl)-6-phenyl-5-oxa-2,6-diazaspiro[3.4]octan-1-one
C25H22N2O4
Acta Crystallographica Section C (2000) 56, 4 473-474
a=9.368(5)Å b=19.776(7)Å c=11.484(8)Å
α=90.00° β=101.92(4)° γ=90.00°
6-tert-butyl-2-(4-methylphenyl)-7-phenyl-5-oxa-2,6-diazaspiro[3.4]octan-1-one
C22H26N2O2
Acta Crystallographica Section C (2000) 56, 4 473-474
a=6.272(2)Å b=10.687(3)Å c=15.327(4)Å
α=103.39(2)° β=87.79(3)° γ=95.62(2)°
2-[2-oxo-4-(E)-styryl-N-{[2,2,2',2'-tetramethyl-4,4'-bi(1,3- dioxolanyl)-5-yl]-1,3-dithian-2-ylmethyl}-azetidin-3-yl]isoindol-1,3-dione
C34H38N2O7S2,C4H8O2
Acta Crystallographica Section C (1994) 50, 9 1474-1480
a=9.518(8)Å b=16.941(12)Å c=24.261(18)Å
α=90.00° β=90.00° γ=90.00°
1-{[2,2,2',2'-tetramethyl-4,4'-bi(1,3- dioxolanyl)-5-yl]-1,3-dithian-2-ylmethyl}-3-methoxy-4-(E)-styrylazetidin-2-one
C27H37NO6S2
Acta Crystallographica Section C (1994) 50, 9 1474-1480
a=9.038(4)Å b=9.488(4)Å c=10.443(6)Å
α=92.07(3)° β=109.45(3)° γ=120.31(4)°
3-butyl-1-{[2,2,2',2'-tetramethyl-4,4'-bi(1,3- dioxolanyl)-5-yl]-1,3-dithian-2-ylmethyl}-4-[1-methyl-(Z)-styryl]azetidin-2-one
C31H45N1O5S2
Acta Crystallographica Section C (1994) 50, 9 1474-1480
a=10.770(7)Å b=14.355(10)Å c=20.690(15)Å
α=90.00° β=90.00° γ=90.00°
N-4-[4-amino-(N-6-formyl-N-6-beta-ribofuranosyl)pyrimidin-5-yl]-5-methyl-2'- deoxycytidine
C20H27N7O9,2H2O
Journal of the American Chemical Society (1996) 118, 8142-8143
a=7.381(7)Å b=21.298(12)Å c=8.414(10)Å
α=90.00° β=108.92(8)° γ=90.00°
(+)-Pseudoconhydrine hydrochloride
C8H18N1O11,Cl11
Liebigs Ann.Chem. (1997) 1267
a=7.442(2)Å b=9.400(2)Å c=14.644(3)Å
α=90° β=90° γ=90°